India's Rubicon Research hits record high as quarterly profit nearly doubles
** Shares of Rubicon Research RUBI.NS jump as much as 13% to a record high of 789 rupees, last up 4% ** Stock up for a third straight session ** Pharmaceutical formulations co's Q3 consol net profit nearly doubles to 728 mln rupees ($8.04 mln); rev from ops rises 51.7% y/y ** Stock up about ~21 from market debut in October 16, 2025 ($1 = 90.5200 Indian rupees) (Reporting by Brijesh Patel in Bengaluru) ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))
Recent news on Rubicon Research
See all newsIndia's Rubicon Research hits record high after quarterly profit more than doubles
Brief: Rubicon Research Says Total Tax Demand Raised Amounts To 172.5 Million Rupees
Brief: Rubicon Research To Buy 85% Stake In Arinna Lifesciences
Brief: Rubicon Research Buys 85% Equity Ownership In Arinna Lifesciences
India's Rubicon Research hits record high as quarterly profit nearly doubles